Position in BLLN
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$99,463,846
-$4,322,611 QoQ
Shares Held
1,259,993
-0.6% QoQ
Ownership
2.74%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#2
of 88 holders
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 93.26305781063863.ToString("F0")%
Shared 0.ToString("F0")%
None 6.736942189361369.ToString("F0")%
Common Shares in BLLN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026BAILLIE GIFFORD & CO holds $1,287,817,046 across 6 Diagnostics & Research names. BLLN ranks #5 (7.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GH |
Guardant Health, Inc.
|
3,859,046 | $356,460,077 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
698,441 | $343,304,703 | |
| 3 | MEDP |
Medpace Holdings, Inc.
|
503,191 | $241,627,283 | |
| 4 | ILMN |
Illumina, Inc.
|
1,535,106 | $189,217,163 | |
| 5 | BLLN |
BillionToOne, Inc.
This page
|
1,259,993 | $99,463,846 | |
| 6 | TWST |
Twist Bioscience Corp
|
1,215,151 | $57,743,974 |
All Filings in BLLN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $99,463,846 | 1,259,993 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $103,786,457 | 1,268,163 | Shares | Defined | 2026-01-23 | |
| No filing history on record for this holder in this stock. | ||||||